Cargando…
The Prognostic Efficacy of DPP-4 Inhibitors in Asian HFpEF: Do They Still Have a Chance?
[Figure: see text]
Autores principales: | Chikata, Yuichi, Iwata, Hiroshi, Minamino, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982220/ https://www.ncbi.nlm.nih.gov/pubmed/36873754 http://dx.doi.org/10.1016/j.jacasi.2022.11.008 |
Ejemplares similares
-
Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022) -
Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns
por: Sharp, Thomas E., et al.
Publicado: (2019) -
Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022) -
Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021) -
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
por: Borlaug, Barry A., et al.
Publicado: (2023)